Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TB-402 vs Rivaroxaban for VTE Prophylaxis After Total Hip Replacement
NCT01344954Phase 2Completed
- Sponsor
- Oxurion
- Start
- Apr 2011
- Primary completion
- Dec 2011
- Modality
- Monoclonal Antibodies
- Countries
- 9
01
Overview
A Phase 2 trial of vunacizumab in venous thromboembolism (VTE), sponsored by Oxurion. Started Apr 2011; status: completed.
02
Drugs
vunacizumab
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01344954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01344954.